COST-UTILITY ANALYSIS OF DIENOGEST VERSUS GNRH ANALOGUE IN THE TREATMENT OF ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN IN SLOVAKIA

被引：1
|
作者：
Lukac, M. [1 ]
Knight, C. [2 ]
Bielik, J. [3 ]
Tomek, D. [4 ]
Foltan, V [5 ]
Kovac, A. [1 ]
Bojnicky, M. [1 ]
机构：
[1] Slovak Med Univ, Bratislava, Slovakia
[2] RTI Hlth Solut, Sheffield, S Yorkshire, England
[3] Trencin Univ, Trencin, Slovakia
[4] Slovak Soc Pharmacoecon, Bratislava, Slovakia
[5] Comenius Univ, Fac Pharm, Bratislava, Slovakia
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.606
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [31] PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF 3 VERSUS 6 MONTHS OF NAFARELIN THERAPY FOR ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN
    HORNSTEIN, MD
    YUZPE, AA
    BURRY, KA
    HEINRICHS, LR
    BUTTRAM, VL
    ORWOLL, ES
    FERTILITY AND STERILITY, 1995, 63 (05) : 955 - 962
  • [32] An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: Placebo-controlled studies
    Howard, FM
    JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 2000, 7 (04): : 477 - 488
  • [33] Laparoscopic Excision Versus Ablation for Endometriosis-associated Pain: An Updated Systematic Review and Meta-analysis
    Pundir, Jyotsna
    Omanwa, Kireki
    Kovoor, Elias
    Pundir, Vishal
    Lancaster, Gillian
    Barton-Smith, Peter
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2017, 24 (05) : 747 - 756
  • [34] COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES
    Yakovlev, M., V
    Kulikov, A. U.
    Sokov, E. L.
    Kornilova, L. E.
    VALUE IN HEALTH, 2012, 15 (07) : A553 - A553
  • [35] Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain
    Rivero-Arias, Oliver
    Gray, Alastair
    Frost, Helen
    Lamb, Sarah E.
    Stewart-Brown, Sarah
    SPINE, 2006, 31 (12) : 1381 - 1387
  • [36] A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy
    Anis, AH
    Sun, HY
    Singh, S
    Woolcott, J
    Nosyk, B
    Brisson, M
    PHARMACOECONOMICS, 2006, 24 (04) : 387 - 400
  • [37] Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis
    Liu, Chang
    Wu, Yao
    Wang, Fangxu
    Sun, Shuang
    Wei, Jiayin
    Tao, Libo
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [38] Cost-Utility Analysis of Operative Versus Nonoperative Treatment of Thoracic Adolescent Idiopathic Scoliosis
    Jain, Amit
    Marks, Michelle C.
    Kelly, Michael P.
    Lenke, Lawrence G.
    Errico, Thomas J.
    Lonner, Baron S.
    Newton, Peter O.
    Sponseller, Paul D.
    SPINE, 2019, 44 (05) : 309 - 317
  • [39] A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy
    Aslam H. Anis
    Huiying Sun
    Sonia Singh
    John Woolcott
    Bohdan Nosyk
    Marc Brisson
    PharmacoEconomics, 2006, 24 : 387 - 400
  • [40] Domiciliary liquid oxygen versus concentrator treatment:: In chronic hypoxaemia:: a cost-utility analysis
    Andersson, A
    Ström, K
    Brodin, H
    Alton, M
    Boman, G
    Jakobsson, P
    Lindberg, A
    Uddenfeldt, M
    Walter, H
    Levin, LÅ
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (06) : 1284 - 1289
12345